These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23773030)

  • 21. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
    Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
    J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
    Hobson P; Meara J
    Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease.
    Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ
    Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
    Mamikonyan E; Moberg PJ; Siderowf A; Duda JE; Have TT; Hurtig HI; Stern MB; Weintraub D
    Parkinsonism Relat Disord; 2009 Mar; 15(3):226-31. PubMed ID: 18595765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating cognitive impairment in the early stages of Parkinson's disease using the Cambridge brain sciences-cognitive platform.
    Hosseini M; Borhani-Haghighi A; Petramfar P; Foroughi AA; Ostovan VR; Nami M
    Clin Neurol Neurosurg; 2023 Sep; 232():107866. PubMed ID: 37413872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
    Alty JE; Cosgrove J; Jamieson S; Smith SL; Possin KL
    Clin Neurol Neurosurg; 2015 Dec; 139():244-6. PubMed ID: 26519897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease.
    Breder R; Leite MAA; Pinto JA; Cavalcante IP; Pessoa BL; Neves MAO
    J Geriatr Psychiatry Neurol; 2017 Nov; 30(6):311-315. PubMed ID: 28969462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes on brief cognitive instruments over time in Parkinson's disease.
    Lessig S; Nie D; Xu R; Corey-Bloom J
    Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.
    Ihara M; Okamoto Y; Takahashi R
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):737-41. PubMed ID: 22306380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between olfactory loss and cognitive deficits in Parkinson's disease.
    Camargo CHF; Jobbins VA; Serpa RA; Berbetz FA; Sabatini JS; Teive HAG
    Clin Neurol Neurosurg; 2018 Oct; 173():120-123. PubMed ID: 30121454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.